OpenVSafe by OpenVAERS
Search V-safe

3NX-23120-06453

3 vaccinations 2 coded responses 6 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
633 / MO
Registered
2021-03-17
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-17
    Registered in v-safe
  2. 2021-03-17
    Dose 1 — Moderna
  3. 2021-03-17
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-03-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-03-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  6. 2021-04-17
    Dose 2 — Moderna
  7. 2021-09-17
    Health check-in — 6 months, dose 1
    Feeling: Fair
    Adult check-in
  8. 2022-01-07
    Dose 3 — Moderna
  9. 2022-04-19
    Survey response — 12 months, dose 2
    MedDRA: Influenza — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Flu symptoms
    MedDRA releases: 2024-11 · check-in free text available
  10. 2023-01-07
    Survey response — 12 months, dose 3
    MedDRA: Chest pain, Oropharyngeal pain, Productive cough, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  11. 2023-01-07
    Report sent to call center — 12 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  12. 2023-01-09
  13. 2023-01-12
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-03-17Moderna
22021-04-17Moderna No
32022-01-07Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2023-01-07 Successful
2023-01-12
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 11 — 12 months, dose 2

2022-04-19

Symptoms: Flu symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChest pain · · ✓
SDInfluenza · · ✓
SDOropharyngeal pain · · ✓
SDProductive cough · · ✓
SDPyrexia · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release